» Authors » Rosanne J H C G Beijers

Rosanne J H C G Beijers

Explore the profile of Rosanne J H C G Beijers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 273
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Blankestijn J, Baalbaki N, Beijers R, Cornelissen M, Wiersinga W, I Abdel-Aziz M, et al.
Int J Mol Sci . 2025 Feb; 26(4). PMID: 40004244
An estimated 10% of COVID-19 survivors have been reported to suffer from complaints after at least three months. The intestinal microbiome has been shown to impact long COVID through the...
2.
Cornelissen M, Haarman M, Twisk J, Houweling L, Baalbaki N, Sondermeijer B, et al.
Biomedicines . 2024 Nov; 12(11). PMID: 39595059
Background: Although the coronavirus disease 2019 (COVID-19) pandemic is no longer a public health emergency of international concern, 30% of COVID-19 patients still have long-term complaints. A better understanding of...
3.
Gach D, Beijers R, van Zeeland R, van Kampen-van den Boogaart V, Posthuma R, Schols A, et al.
Sci Rep . 2024 Jul; 14(1):16571. PMID: 39019957
A significant proportion of COVID-19 survivors still experience a reduced diffusion capacity three and twelve months after discharge. We aimed to compare pulmonary function trajectories between hospitalized COVID-19 patients with...
4.
Bazdar S, Bloemsma L, Baalbaki N, Blankestijn J, Cornelissen M, Beijers R, et al.
Biomedicines . 2024 Jun; 12(6). PMID: 38927441
While some long-term effects of COVID-19 are respiratory in nature, a non-respiratory effect gaining attention has been a decline in hemoglobin, potentially mediated by inflammatory processes. In this study, we...
5.
Blankestijn J, Baalbaki N, Bazdar S, Beekers I, Beijers R, van den Bergh J, et al.
J Allergy Clin Immunol . 2024 Jun; 154(3):807-818. PMID: 38830512
Background: Months after infection with severe acute respiratory syndrome coronavirus 2, at least 10% of patients still experience complaints. Long-COVID (coronavirus disease 2019) is a heterogeneous disease, and clustering efforts...
6.
Born C, Bhadra R, DSouza G, Kremers S, Sambashivaiah S, Schols A, et al.
Nutrients . 2024 May; 16(10). PMID: 38794757
(1) Background: A healthy lifestyle has a protective role against the onset and management of asthma and chronic obstructive pulmonary disease (COPD). Therefore, combined lifestyle interventions (CLIs) are a potentially...
7.
Blankestijn J, I Abdel-Aziz M, Baalbaki N, Bazdar S, Beekers I, Beijers R, et al.
BMJ Open Respir Res . 2024 Apr; 11(1). PMID: 38663887
Background: Four months after SARS-CoV-2 infection, 22%-50% of COVID-19 patients still experience complaints. Long COVID is a heterogeneous disease and finding subtypes could aid in optimising and developing treatment for...
8.
Cornelissen M, Bloemsma L, Vaes A, Baalbaki N, Deng Q, Beijers R, et al.
J Transl Med . 2024 Feb; 22(1):191. PMID: 38383493
Background: In the Netherlands, the prevalence of post COVID-19 condition is estimated at 12.7% at 90-150 days after SARS-CoV-2 infection. This study aimed to determine the occurrence of fatigue and...
9.
Brauwers B, Machado F, Beijers R, Spruit M, Franssen F
Nutrients . 2023 Dec; 15(24). PMID: 38140395
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease that is associated with significant morbidity, mortality, and healthcare costs. The burden of respiratory symptoms and airflow limitation can translate...
10.
Baalbaki N, Blankestijn J, I Abdel-Aziz M, De Backer J, Bazdar S, Beekers I, et al.
J Pers Med . 2023 Jul; 13(7). PMID: 37511673
: The coronavirus disease 2019 (COVID-19) pandemic has led to the death of almost 7 million people, however, with a cumulative incidence of 0.76 billion, most people survive COVID-19. Several...